96 related articles for article (PubMed ID: 8265428)
1. The role of fibrinolytic agents in the management of thrombotic complications associated with vascular access devices.
Cunningham RS; Bonam-Crawford D
Nurs Clin North Am; 1993 Dec; 28(4):899-909. PubMed ID: 8265428
[TBL] [Abstract][Full Text] [Related]
2. Managing catheter dysfunction for better patient outcomes: a team approach.
Dinwiddie LC
Nephrol Nurs J; 2004; 31(6):653-60, 671; quiz 661-2. PubMed ID: 15686329
[TBL] [Abstract][Full Text] [Related]
3. Nurse's guide to understanding and treating thrombotic occlusion of central venous access devices.
McKnight S
Medsurg Nurs; 2004 Dec; 13(6):377-82. PubMed ID: 15714740
[TBL] [Abstract][Full Text] [Related]
4. Managing vascular access device occlusions, Part. 1.
Hadaway LC
Nursing; 2000 Jul; 30(7):20. PubMed ID: 10983093
[No Abstract] [Full Text] [Related]
5. [Tesio twin catheter system for hemodialysis tunnelized using an echo-guided technique. Retrospective analysis of 210 catheters].
Ibrik O; Samon R; Roca R; Viladoms J; Mora J
Nefrologia; 2006; 26(6):719-25. PubMed ID: 17227250
[TBL] [Abstract][Full Text] [Related]
6. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure.
Wijnen E; Planken N; Keuter X; Kooman JP; Tordoir JH; de Haan MW; Leunissen KM; van der Sande F
Nephrol Dial Transplant; 2006 Dec; 21(12):3514-9. PubMed ID: 16921189
[TBL] [Abstract][Full Text] [Related]
7. Noninfectious complications due to vascular access ports (VAPs) in Yucatan minipigs (Sus scrofa domestica).
Ege CA; Parra NC; Johnson TE
J Am Assoc Lab Anim Sci; 2006 Nov; 45(6):27-34. PubMed ID: 17089988
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic and clinical characteristics of thrombolytic agents.
Deitcher SR; Jaff MR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S25-33. PubMed ID: 15112713
[TBL] [Abstract][Full Text] [Related]
9. Guidelines on the insertion and management of central venous access devices in adults.
Bishop L; Dougherty L; Bodenham A; Mansi J; Crowe P; Kibbler C; Shannon M; Treleaven J
Int J Lab Hematol; 2007 Aug; 29(4):261-78. PubMed ID: 17617077
[TBL] [Abstract][Full Text] [Related]
10. Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: a double-blinded, randomized clinical trial.
Frank JL; Garb JL; Halla B; Reed WP
Surgery; 2001 May; 129(5):547-51. PubMed ID: 11331446
[TBL] [Abstract][Full Text] [Related]
11. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis in the pediatric population.
Parker RI
Crit Care Med; 2010 Feb; 38(2 Suppl):S71-5. PubMed ID: 20083917
[TBL] [Abstract][Full Text] [Related]
13. Long-term management of the tunneled venous catheter.
Liangos O; Gul A; Madias NE; Jaber BL
Semin Dial; 2006; 19(2):158-64. PubMed ID: 16551295
[TBL] [Abstract][Full Text] [Related]
14. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
Lee YK; Koo JR; Kim JK; Park II; Joo MH; Yoon JW; Noh JW; Vaziri ND
Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
[TBL] [Abstract][Full Text] [Related]
15. Current trends in antithrombotic drug and device development.
Fareed J
Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
[TBL] [Abstract][Full Text] [Related]
16. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis.
Nguyen TV; Dikun M
Am J Health Syst Pharm; 2004 Sep; 61(18):1922-4. PubMed ID: 15487882
[No Abstract] [Full Text] [Related]
17. [Analysis of the survival of permanent vascular access ports].
Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
[TBL] [Abstract][Full Text] [Related]
18. [Long-term central venous lines and their complications].
Teichgräber UK; Gebauer B; Benter T; Wagner J
Rofo; 2004 Jul; 176(7):944-52. PubMed ID: 15237335
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue plasminogen activator for central venous access device occlusion.
Hooke C
J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
[TBL] [Abstract][Full Text] [Related]
20. Catheter-related thrombosis in pediatrics.
McCloskey DJ
Pediatr Nurs; 2002; 28(2):97-102, 105-6. PubMed ID: 11962187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
